All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
In the current situation of Aethlon Medical there is not any eligible buy setup. This doesn't mean AEMD will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems
Knowing when to sell a stock is even more difficult than knowing when to buy it. Trading strategies allow us to avoid impetuous decisions based on our moods or the buzz surrounding the market. When selling, as well as buying, our strategies are very simple to follow and are only valid for selling stocks in your porfolio, not for selling short Aethlon Medical stock
A golden rule is that you should never hold an operation that shows a greater losses than those expected by the time of the buy. The timing to sell shares should always be dictated by the stop-loss (automatic or manual)
In the current situation of Aethlon Medical there is not any eligible sell setup, so Aethlon Medical stock holders with operations in profit can keep their positions
Brokerage firms and financial institutions post stock ratings based on their views of the market and the fundamental and technical situation of the analyzed stock. Unfortunately, the accuracy of these predictions is not very high, and certainly not a direct buy or sell signal
In the last month we couldn't find any rating for Aethlon Medical
Moving averages are tools for investors to detect momentum. A moving average is calculated as the simple mean of the previous N periods (usually sessions). Usual time periods used for moving averages are 21 days, 50 days, 100 days and 200 days
Investors use support and resistance levels to spot price points in the stock price action that may work as barriers, preventing the price of shares to move in certain direction. Supports are levels where the price may stop as it falls. Price is more likely to "rebound" this level rather than break through it. Nevertheless, if the price breaks down the support, it will probably continue declining until finding another support level. On the other side, a resistance level is where the price tends to find opposition as it rises. In the same way, the price is more likely to "bounce off" at this level, and if it finally crosses this level, it will rally easily until it finds the next resistance
The current resistance levels are:
The current supports are:
This is an indicator that was introduced in the 1980s by John Bollinger. Basically, the Bollinger Bands are bands that run around a centralmoving average, varying the distance from the bottom to the top depending on market volatility. They are usually drawn by an interval of two standard deviations, above and below, from a moving average line. Bollinger himself recommends the moving average period to be 20
The RSI (Relative Strength Index) is an oscillator-type indicator that gauges price movements to reveal when the share or financial asset is oversold or overbought. Like other oscillation indicators, the RSI moves from 0 to 100. The relative strength indicator is one of the best known and most widely used indicators, and it was invented by J. Welles Wilder in 1978
The RSI dropped below the overbought level of 70 in mid-June after just crossing to the overbough zone for a single day (weak signal). The RSI reading on Friday was 47.58. Aethlon Medical price dropped a 27.17% since RSI lost the overbought zone
Aethlon Medical Inc. (AEMD) came out with quarterly earnings of $-0.22 per share, poorly missing the Wall St consensus estimate of $-0.16 per share. This quarterly report means an earnings surprise of -37.5%. Estimated turnover was $500,000 but Aethlon Medical slightly enhanced by 100%, reporting $0.00.
In comparing, the EPS for the same quarter last year was $-1.35, so posted EPS is a increase of 83.7%. Turnover exploded a 176.33% on an annualized basis in the 2nd-quarter, from $748,120 to $2,067,290 last quarter.
Aethlon Medical will host the earnings call next October. Estimated earnings of %s per-share for this quarter is $0.00. If you hold or you are planning to buy Aethlon Medical stock, be on your toes as financial reporting day usually has a higher than usual volatility, and price can soar and sink with exceptionally low liquidity and not respecting your buy/stop-loss orders. You can uncover more information about the earnings call and the earnings reports on the Investor Relations section of its website: http://www.aethlonmedical.com.